Who invested in NILO Therapeutics?
NILO Therapeutics's investors include Lux Capital, DCVC and Alexandria Venture Investments.
United States · Series A startup
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$101Mraised across 1 round since 2025, from 1 source
NILO Therapeutics's investors include Lux Capital, DCVC and Alexandria Venture Investments.
NILO Therapeutics has raised $101M across 1 round since 2025.
NILO Therapeutics's most recent round was a Series A of $101M in Oct 2025.
Its most recent round, $101M in Oct 2025, is also its largest on record.
NILO Therapeutics's first round on record, in Oct 2025, was backed by Lux Capital, DCVC and Alexandria Venture Investments.
NILO Therapeutics's latest named round is a Series A, in Oct 2025.
NILO Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.